Calcium channel blockers are drugs that lower your blood pressure by relaxing the muscles that control the arteries. ... Next In Pulmonary Arterial Hypertension. How to Monitor Your PAH ; ...

Other Ways to Treat Pulmonary Arterial Hypertension. These include: Calcium channel blockers. This class of drugs, in select patients, can help lower the blood pressure in your lungs.

The FDA has granted orphan drug designation to AISA-021, a fourth-generation calcium channel blocker, for the treatment of systemic sclerosis, according to a press release from Aisa Pharma.The ...

NEW YORK, July 31 (Praxis Press) Cardiovascular outcomes have not been compared in hypertensive patients treated with calcium channel blockers and in patients treated with older drugs. Hansson and ...

The retrospective cohort study, published in JAMA Neurology, 1 used propensity score matching to evaluate 619,858 patients for ARBs vs angiotensin-converting enzyme (ACE) inhibitors; 619,828 ...

Sitbon O, Humbert M, Jaïs X, Ioos V, Hamid AM, Provencher S, Garcia G, ParentHervé P, Simonneau G. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.

Nearly 70 years ago, the eminent British cardiologist Paul Wood first described a subject with pulmonary artery hypertension (PAH) in whom the acute administration of acetylcholine induced a marked ...

Calcium channel blockers (CCBs) are the oldest drugs to manage pulmonary hypertension. Until now, CCBs are still the first choice of a certain kind of pulmonary arterial hypertension. And more ...

A new research paper was published in Aging, entitled, “Benidipine calcium channel blocker promotes the death of cigarette smoke-induced senescent cells and improves lung emphysema.” ...

More information: Alberta Palazzo et al, Benidipine calcium channel blocker promotes the death of cigarette smoke-induced senescent cells and improves lung emphysema, Aging (2023). DOI: 10.18632 ...

The use of calcium channel blockers may lead to glaucomatous damage and macular structural changes. Calcium channel blocker use demonstrates an adverse association with glaucoma, and can result in ...